The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Targeting Notch signaling pathway in cancer: Clinical development advances and challenges
Open accessAbstract
Notch signaling plays an important role in development and cell fate determination, and it is deregulated in human hematologic malignancies and solid tumors. This review includes a brief introduction of the relevant pathophysiology of Notch signaling pathway and primarily focuses on the clinical development of promising agents that either obstruct Notch receptor cleavages such as γ-secretase inhibitors (GSIs) or interfere with the Notch ligand–receptor interaction by monoclonal antibodies (mAbs). Antitumor activity by GSIs and mAbs administered as single agent in early phases of clinical trials has been observed in advanced or metastatic thyroid cancer, non-small cell lung cancer, intracranial tumors, sarcoma or desmoid tumors, colorectal cancer with neuroendocrine features, melanoma and ovarian cancer. A number of mechanism-based adverse events particularly gastrointestinal toxicities emerged and mitigation strategies are developed after testing multiple GSIs and Notch targeting mAbs. We also discuss pharmacodynamic biomarkers in conjunction with methods of assessment of the molecular target inhibition validation. Biomarkers of efficacy or benefit may be of importance for a successful development of this class of drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,012
Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia
Weng, A. P., Ferrando, A. A., Lee, W., Morris, J. P., Silverman, L. B., Sanchez-Irizarry, C., Blacklow, S. C., Look, A. T., & Aster, J. C. (2004) · Science · doi:10.1126/science.1102160 · Cited by 2,715
A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain
De Strooper, B., Annaert, W., Cupers, P., Saftig, P., Craessaerts, K., Mumm, J. S., Schroeter, E. H., Schrijvers, V., Wolfe, M. S., Ray, W. J., et al. (1999) · Nature · doi:10.1038/19083 · Cited by 2,100
Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis
Hellström, M., Phng, L.-K., Hofmann, J. J., Wallgard, E., Coultas, L., Lindblom, P., Alva, J., Nilsson, A.-K., Karlsson, L., Gaiano, N., et al. (2007) · Nature · doi:10.1038/nature05571 · Cited by 1,775
Ellisen, L. W., Bird, J., West, D. C., Soreng, A. L., Reynolds, T. C., Smith, S. D., & Sklar, J. (1991) · Cell · doi:10.1016/0092-8674(91)90111-b · Cited by 1,696
van Es, J. H., van Gijn, M. E., Riccio, O., van den Born, M., Vooijs, M., Begthel, H., Cozijnsen, M., Robine, S., Winton, D. J., Radtke, F., et al. (2005) · Nature · doi:10.1038/nature03659 · Cited by 1,543
The adult Drosophila posterior midgut is maintained by pluripotent stem cells
Ohlstein, B., & Spradling, A. (2006) · Nature · doi:10.1038/nature04333 · Cited by 1,083
Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis
Noguera-Troise, I., Daly, C., Papadopoulos, N. J., Coetzee, S., Boland, P., Gale, N. W., Chieh Lin, H., Yancopoulos, G. D., & Thurston, G. (2006) · Nature · doi:10.1038/nature05355 · Cited by 1,032
Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways
Takebe, N., Harris, P. J., Warren, R. Q., & Ivy, S. P. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.196 · Cited by 992
Self-citationInhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis
Ridgway, J., Zhang, G., Wu, Y., Stawicki, S., Liang, W.-C., Chanthery, Y., Kowalski, J., Watts, R. J., Callahan, C., Kasman, I., et al. (2006) · Nature · doi:10.1038/nature05313 · Cited by 986
Timmerman, L. A., Grego-Bessa, J., Raya, A., Bertrán, E., Pérez-Pomares, J. M., Díez, J., Aranda, S., Palomo, S., McCormick, F., Izpisúa-Belmonte, J. C., et al. (2004) · Genes & Development · doi:10.1101/gad.276304 · Cited by 985
Notch signalling regulates stem cell numbers in vitro and in vivo
Androutsellis-Theotokis, A., Leker, R. R., Soldner, F., Hoeppner, D. J., Ravin, R., Poser, S. W., Rueger, M. A., Bae, S.-K., Kittappa, R., & McKay, R. D. G. (2006) · Nature · doi:10.1038/nature04940 · Cited by 956
Notch signals control the fate of immature progenitor cells in the intestine
Fre, S., Huyghe, M., Mourikis, P., Robine, S., Louvard, D., & Artavanis-Tsakonas, S. (2005) · Nature · doi:10.1038/nature03589 · Cited by 935
c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma
Weng, A. P., Millholland, J. M., Yashiro-Ohtani, Y., Arcangeli, M. L., Lau, A., Wai, C., del Bianco, C., Rodriguez, C. G., Sai, H., Tobias, J., et al. (2006) · Genes & Development · doi:10.1101/gad.1450406 · Cited by 870
Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation
Rangarajan, A. (2001) · The EMBO Journal · doi:10.1093/emboj/20.13.3427 · Cited by 866
Angiogenesis: A Team Effort Coordinated by Notch
Phng, L.-K., & Gerhardt, H. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.01.015 · Cited by 832
Notch signalling in solid tumours: a little bit of everything but not all the time
Ranganathan, P., Weaver, K. L., & Capobianco, A. J. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3035 · Cited by 824
γ-Secretase-mediated proteolysis in cell-surface-receptor signalling
Fortini, M. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm910 · Cited by 824
Suchting, S., Freitas, C., le Noble, F., Benedito, R., Bréant, C., Duarte, A., & Eichmann, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611177104 · Cited by 811
Reedijk, M., Odorcic, S., Chang, L., Zhang, H., Miller, N., McCready, D. R., Lockwood, G., & Egan, S. E. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1069 · Cited by 783
Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting
Lobov, I. B., Renard, R. A., Papadopoulos, N., Gale, N. W., Thurston, G., Yancopoulos, G. D., & Wiegand, S. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611206104 · Cited by 774
Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells
Dontu, G., Jackson, K. W., McNicholas, E., Kawamura, M. J., Abdallah, W. M., & Wicha, M. S. (2004) · Breast Cancer Research · doi:10.1186/bcr920 · Cited by 762
Direct inhibition of the NOTCH transcription factor complex
Moellering, R. E., Cornejo, M., Davis, T. N., Bianco, C. D., Aster, J. C., Blacklow, S. C., Kung, A. L., Gilliland, D. G., Verdine, G. L., & Bradner, J. E. (2009) · Nature · doi:10.1038/nature08543 · Cited by 752
Therapeutic antibody targeting of individual Notch receptors
Wu, Y., Cain-Hom, C., Choy, L., Hagenbeek, T. J., de Leon, G. P., Chen, Y., Finkle, D., Venook, R., Wu, X., Ridgway, J., et al. (2010) · Nature · doi:10.1038/nature08878 · Cited by 720
Nuclear signalling by tumour-associated antigen EpCAM
Maetzel, D., Denzel, S., Mack, B., Canis, M., Went, P., Benk, M., Kieu, C., Papior, P., Baeuerle, P. A., Munz, M., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1824 · Cited by 719
Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries
Siekmann, A. F., & Lawson, N. D. (2007) · Nature · doi:10.1038/nature05577 · Cited by 687
Notch Promotes Radioresistance of Glioma Stem Cells
Wang, J., Wakeman, T. P., Lathia, J. D., Hjelmeland, A. B., Wang, X.-F., White, R. R., Rich, J. N., & Sullenger, B. A. (2010) · Stem Cells · doi:10.1002/stem.261 · Cited by 656
Fan, X., Khaki, L., Zhu, T. S., Soules, M. E., Talsma, C. E., Gul, N., Koh, C., Zhang, J., Li, Y.-M., Maciaczyk, J., et al. (2010) · Stem Cells · doi:10.1002/stem.254 · Cited by 651
A histone deacetylase corepressor complex regulates the Notch signal transduction pathway
Kao, H.-Y., Ordentlich, P., Koyano-Nakagawa, N., Tang, Z., Downes, M., Kintner, C. R., Evans, R. M., & Kadesch, T. (1998) · Genes & Development · doi:10.1101/gad.12.15.2269 · Cited by 579
Aberrant Activation of Notch Signaling in Human Breast Cancer
Stylianou, S., Clarke, R. B., & Brennan, K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3054 · Cited by 562
γ-Secretase: proteasome of the membrane?
Kopan, R., & Ilagan, M. X. G. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1406 · Cited by 554
Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells
Weijzen, S., Rizzo, P., Braid, M., Vaishnav, R., Jonkheer, S. M., Zlobin, A., Osborne, B. A., Gottipati, S., Aster, J. C., Hahn, W. C., et al. (2002) · Nature Medicine · doi:10.1038/nm754 · Cited by 550
Targeting Notch to Target Cancer Stem Cells
Pannuti, A., Foreman, K., Rizzo, P., Osipo, C., Golde, T., Osborne, B., & Miele, L. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2823 · Cited by 450
γ-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia
Real, P. J., Tosello, V., Palomero, T., Castillo, M., Hernando, E., de Stanchina, E., Sulis, M. L., Barnes, K., Sawai, C., Homminga, I., et al. (2009) · Nature Medicine · doi:10.1038/nm.1900 · Cited by 445
Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels
Villa, N., Walker, L., Lindsell, C. E., Gasson, J., Iruela-Arispe, M. L., & Weinmaster, G. (2001) · Mechanisms of Development · doi:10.1016/s0925-4773(01)00469-5 · Cited by 429
Endothelial signalling by the Notch ligand Delta-like 4 restricts angiogenesis
Leslie, J. D., Ariza-McNaughton, L., Bermange, A. L., McAdow, R., Johnson, S. L., & Lewis, J. (2007) · Development · doi:10.1242/dev.003244 · Cited by 415
Ronchini, C., & Capobianco, A. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.17.5925-5934.2001 · Cited by 412
Calcium Depletion Dissociates and Activates Heterodimeric Notch Receptors
Rand, M. D., Grimm, L. M., Artavanis-Tsakonas, S., Patriub, V., Blacklow, S. C., Sklar, J., & Aster, J. C. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1825-1835.2000 · Cited by 408
Mammary Stem Cells and Breast Cancer—Role of Notch Signalling
Farnie, G., & Clarke, R. B. (2007) · Stem Cell Reviews · doi:10.1007/s12015-007-0023-5 · Cited by 356
Alterations in Notch signaling in neoplastic lesions of the human cervix.
Zagouras, P., Stifani, S., Blaumueller, C. M., Carcangiu, M. L., & Artavanis-Tsakonas, S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.14.6414 · Cited by 352
Wang, Z., Li, Y., Kong, D., & H. Sarkar, F. (2010) · Current Drug Targets · doi:10.2174/138945010791170860 · Cited by 341
Requirement for cyclin D3 in lymphocyte development and T cell leukemias
Sicinska, E., Aifantis, I., Le Cam, L., Swat, W., Borowski, C., Yu, Q., Ferrando, A. A., Levin, S. D., Geng, Y., von Boehmer, H., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00301-5 · Cited by 340
JAGGED1 Expression Is Associated with Prostate Cancer Metastasis and Recurrence
Santagata, S., Demichelis, F., Riva, A., Varambally, S., Hofer, M. D., Kutok, J. L., Kim, R., Tang, J., Montie, J. E., Chinnaiyan, A. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2500 · Cited by 338
Nickoloff, B. J., Qin, J.-Z., Chaturvedi, V, Denning, M. F., Bonish, B., & Miele, L. (2002) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401036 · Cited by 323
Krop, I., Demuth, T., Guthrie, T., Wen, P. Y., Mason, W. P., Chinnaiyan, P., Butowski, N., Groves, M. D., Kesari, S., Freedman, S. J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.1540 · Cited by 318
Vasko, V., Espinosa, A. V., Scouten, W., He, H., Auer, H., Liyanarachchi, S., Larin, A., Savchenko, V., Francis, G. L., de la Chapelle, A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610733104 · Cited by 310
Nickoloff, B. J., Osborne, B. A., & Miele, L. (2003) · Oncogene · doi:10.1038/sj.onc.1206758 · Cited by 306
Chronic DLL4 blockade induces vascular neoplasms
Yan, M., Callahan, C. A., Beyer, J. C., Allamneni, K. P., Zhang, G., Ridgway, J. B., Niessen, K., & Plowman, G. D. (2010) · Nature · doi:10.1038/nature08751 · Cited by 280
Notch signaling regulates tumor angiogenesis by diverse mechanisms
Dufraine, J., Funahashi, Y., & Kitajewski, J. (2008) · Oncogene · doi:10.1038/onc.2008.227 · Cited by 277
Preclinical and Clinical Studies of Gamma Secretase Inhibitors with Docetaxel on Human Breast Tumors
Schott, A. F., Landis, M. D., Dontu, G., Griffith, K. A., Layman, R. M., Krop, I., Paskett, L. A., Wong, H., Dobrolecki, L. E., Lewis, M. T., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3326 · Cited by 277
Tolcher, A. W., Messersmith, W. A., Mikulski, S. M., Papadopoulos, K. P., Kwak, E. L., Gibbon, D. G., Patnaik, A., Falchook, G. S., Dasari, A., Shapiro, G. I., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.8282 · Cited by 268
Kummar, S., Chen, A., Ji, J., Zhang, Y., Reid, J. M., Ames, M., Jia, L., Weil, M., Speranza, G., Murgo, A. J., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1227 · Cited by 259
Kummar, S., Chen, H. X., Wright, J., Holbeck, S., Millin, M. D., Tomaszewski, J., Zweibel, J., Collins, J., & Doroshow, J. H. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3216 · Cited by 247
Deangelo, D. J., Stone, R. M., Silverman, L. B., Stock, W., Attar, E. C., Fearen, I., Dallob, A., Matthews, C., Stone, J., Freedman, S. J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.24.18_suppl.6585 · Cited by 229
Notch Signaling in Blood Vessels: Who Is Talking to Whom About What?
Hofmann, J. J., & Iruela-Arispe, M. L. (2007) · Circulation Research · doi:10.1161/01.res.0000266408.42939.e4 · Cited by 225
Notch-1 Regulates NF-κB Activity in Hemopoietic Progenitor Cells
Cheng, P., Zlobin, A., Volgina, V., Gottipati, S., Osborne, B., Simel, E. J., Miele, L., & Gabrilovich, D. I. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4458 · Cited by 216
Hassan, K. A., Wang, L., Korkaya, H., Chen, G., Maillard, I., Beer, D. G., Kalemkerian, G. P., & Wicha, M. S. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0370 · Cited by 199
Wei, P., Walls, M., Qiu, M., Ding, R., Denlinger, R. H., Wong, A., Tsaparikos, K., Jani, J. P., Hosea, N., Sands, M., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0034 · Cited by 195
Notch1 modulates timing of G1-S progression by inducing SKP2 transcription and p27Kip1 degradation
Sarmento, L. M., Huang, H., Limon, A., Gordon, W., Fernandes, J., Tavares, M. J., Miele, L., Cardoso, A. A., Classon, M., & Carlesso, N. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050559 · Cited by 191
Dontu, G., & Wicha, M. S. (2005) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-005-2542-5 · Cited by 187
Gamma secretase inhibitors of Notch signaling
Osipo, C., Zlobin, & Olsauskas-Kuprys (2013) · OncoTargets and Therapy · doi:10.2147/ott.s33766 · Cited by 174
Crosstalk between Wnt and Notch signaling in intestinal epithelial cell fate decision
Nakamura, T., Tsuchiya, K., & Watanabe, M. (2007) · Journal of Gastroenterology · doi:10.1007/s00535-007-2087-z · Cited by 171
Schreck, K. C., Taylor, P., Marchionni, L., Gopalakrishnan, V., Bar, E. E., Gaiano, N., & Eberhart, C. G. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1624 · Cited by 167
Fouladi, M., Stewart, C. F., Olson, J., Wagner, L. M., Onar-Thomas, A., Kocak, M., Packer, R. J., Goldman, S., Gururangan, S., Gajjar, A., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.7806 · Cited by 164
Favre, C. J., Mancuso, M. R., Maas, K., McLean, J. W., Bałuk, P., & McDonald, D. M. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00983.2002 · Cited by 161
A Notch1 Ectodomain Construct Inhibits Endothelial Notch Signaling, Tumor Growth, and Angiogenesis
Funahashi, Y., Hernandez, S. L., Das, I., Ahn, A., Huang, J., Vorontchikhina, M., Sharma, A., Kanamaru, E., Borisenko, V., DeSilva, D. M., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6499 · Cited by 160
Garcés, C., Ruiz‐Hidalgo, M. J., de Mora, J. F., Park, C., Miele, L., Goldstein, J., Bonvini, E., Porrás, A., & Laborda, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.47.29729 · Cited by 152
Grudzien, P., Lo, S. S., Albain, K. S., Robinson, P. A., Rajan, P. B., Strack, P. R., Golde, T. E., Miele, L., & Foreman, K. E. (2010) · PubMed · Cited by 143
Crosstalk of VEGF and Notch pathways in tumour angiogenesis: therapeutic implications
Li, J., & Harris, A. L. (2009) · Frontiers in bioscience · doi:10.2741/3438 · Cited by 141
Notch in lung development and lung cancer
Collins, B. J., Kleeberger, W., & Ball, D. W. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.04.015 · Cited by 139
Hendrix, M. J. C., Seftor, R. E. B., Seftor, E. A., Gruman, L. M., Lee, L. M. L., Nickoloff, B. J., Miele, L., Sheriff, D. D., & Schatteman, G. C. (2002) · PubMed · Cited by 138
Mahadevan, D., Chiorean, E. G., Harris, W. B., Hoff, D. D. V., Stejskal-Barnett, A., Qi, W., Anthony, S. P., Younger, A., Rensvold, D., Cordova-Marks, F. M., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.06.027 · Cited by 138
Reynolds, T. C., Smith, S. D., & Sklar, J. (1987) · Cell · doi:10.1016/0092-8674(87)90667-2 · Cited by 137
Periodic Delta-like 4 expression in developing retinal arteries
Claxton, S., & Fruttiger, M. (2004) · Gene Expression Patterns · doi:10.1016/j.modgep.2004.05.004 · Cited by 136
Notch signaling from tumor cells: A new mechanism of angiogenesis
Li, J., & Harris, A. L. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.013 · Cited by 114
Samon, J. B., Castillo-Martín, M., Hadler, M., Ambesi-Impiobato, A., Paietta, E. M., Racevskis, J., Wiernik, P. H., Rowe, J. M., Jakubczak, J. L., Randolph, S., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0938 · Cited by 113
Highly Conserved O-Fucose Sites Have Distinct Effects on Notch1 Function
Rampal, R. K., Arboleda‐Velásquez, J. F., Nita-Lazar, A., Kosik, K. S., & Haltiwanger, R. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506104200 · Cited by 111
Hu, W., Lu, C., Dong, H. H., Huang, J., Shen, D.-Y., Stone, R. L., Nick, A. M., Shahzad, M. M. K., Mora, E., Jennings, N. B., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2719 · Cited by 108
Inhibition of Notch Signaling Blocks Growth of Glioblastoma Cell Lines and Tumor Neurospheres
Chen, J., Kesari, S., Rooney, C., Strack, P. R., Chen, J., Shen, H., Wu, L., & Griffin, J. D. (2010) · Genes & Cancer · doi:10.1177/1947601910383564 · Cited by 104
Impact of Exploratory Biomarkers on the Treatment Effect of Bevacizumab in Metastatic Breast Cancer
Jubb, A. M., Miller, K. D., Rugo, H. S., Harris, A. L., Chen, D., Reimann, J. D., Cobleigh, M., Schmidt, M., Langmuir, V. K., Hillan, K. J., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1791 · Cited by 103
Synergistic Effect of the γ-Secretase Inhibitor PF-03084014 and Docetaxel in Breast Cancer Models
Zhang, C. C., Yan, Z., Zong, Q., et al. (2013) · Stem Cells Translational Medicine · doi:10.5966/sctm.2012-0096 · Cited by 94
Nicastrin regulates breast cancer stem cell properties and tumor growth in vitro and in vivo
Lombardo, Y., Filipović, A., Molyneux, G., Periyasamy, M., Giamas, G., Hu, Y., Trivedi, P. S., Wang, J., Yagüe, E., Michel, L. S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206268109 · Cited by 92
Notch Pathway Is Activated by MAPK Signaling and Influences Papillary Thyroid Cancer Proliferation
Yamashita, A. S., Geraldo, M. V., Fuziwara, C. S., Kulcsar, M. A. V., Friguglietti, C. U. M., da Costa, R. B., Baía, G. S., & Kimura, E. T. (2013) · Translational Oncology · doi:10.1593/tlo.12442 · Cited by 83
Richter, S., Bedard, P. L., Chen, E. X., Clarke, B. A., Tran, B., Hotte, S. J., Stathis, A., Hirte, H. W., Razak, A. R. A., Reedijk, M., et al. (2013) · Investigational New Drugs · doi:10.1007/s10637-013-9965-4 · Cited by 80
Notch and Kras in pancreatic cancer: At the crossroads of mutation, differentiation and signaling
Jean–Paul De La, O., & Murtaugh, L. C. (2009) · Cell Cycle · doi:10.4161/cc.8.12.8744 · Cited by 79
Sahebjam, S., Bedard, P. L., Castonguay, V., Chen, Z., Reedijk, M., Liu, G., Cohen, B. L., Zhang, W.-J., Clarke, B. A., Zhang, T., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.380 · Cited by 75
Zhang, C. C., Pavlíček, A., Zhang, Q., Lira, M. E., Painter, C. L., Yan, Z., Zheng, X., Lee, N. V., Ozeck, M., Qiu, M., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1379 · Cited by 74
Molecular Pathways: Context-Dependent Approaches to Notch Targeting as Cancer Therapy
Egloff, A. M., & Grandis, J. R. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2258 · Cited by 69
Targeting the Notch Pathway: Twists and Turns on the Road to Rational Therapeutics
Aster, J. C., & Blacklow, S. C. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.0992 · Cited by 68
Hayashi, I., Takatori, S., Urano, Y., Miyake, Y., Takagi, J., Sakata‐Yanagimoto, M., Iwanari, H., Osawa, S., Morohashi, Y., Li, T., et al. (2011) · Oncogene · doi:10.1038/onc.2011.265 · Cited by 65
Díaz-Padilla, I., Hirte, H. W., Oza, A. M., Clarke, B. A., Cohen, B. L., Reedjik, M., Zhang, T., Kamel‐Reid, S., Ivy, S. P., Hotte, S. J., et al. (2013) · Investigational New Drugs · doi:10.1007/s10637-013-0001-5 · Cited by 58
LoRusso, P. M., Canetta, R. M., Wagner, J. A., Balogh, E. P., Nass, S. J., Boerner, S. A., & Hohneker, J. A. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2455 · Cited by 55
Wang, H., Chen, Y., Castillo, C. F. F.-D., Yilmaz, Ö. H., & Deshpande, V. (2012) · Modern Pathology · doi:10.1038/modpathol.2012.143 · Cited by 52
He, W., Luistro, L. L., Carvajal, D. M., Smith, M., Nevins, T., Yin, X., Cai, J. J., Higgins, B., Kolinsky, K. D., Rizzo, C., et al. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2011.01.001 · Cited by 51
Reynolds, N. D., Lukacs, N. W., Long, N. C., & Karpus, W. J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100160 · Cited by 50
Delta-Like 4/Notch Pathway Is Differentially Regulated in Benign and Malignant Thyroid Tissues
Geers, C., Colin, I. M., & Gérard, A.-C. (2011) · Thyroid · doi:10.1089/thy.2010.0444 · Cited by 36
Notch signaling in pediatric soft tissue sarcomas
Rota, R., Ciarapica, R., Miele, L., & Locatelli, F. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-141 · Cited by 27
Albain, K. S., Czerlanis, C. M., Zlobin, A., Covington, K., Rajan, P., Godellas, C. V., Bova, D., Lo, S., Robinson, P., Sarker, S., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.sabcs11-s1-5 · Cited by 18
Moving Forward One Notch at a Time
Gounder, M. M., & Schwartz, G. K. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.3277 · Cited by 18
Dose-Levels and First Signs of Efficacy in Contemporary Oncology Phase 1 Clinical Trials
Ferté, C., Soria, J., & Penel, N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016633 · Cited by 16
Jimeno, A., LoRusso, P., Strother, R. M., Diamond, J. R., Plato, L., Younger, A., Messersmith, W. A., Kittaneh, M., Sawyer, D., Adriaens, L., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.15_suppl.2502 · Cited by 15
Tolcher, A. W., Chugh, R. K., Chambers, G., Thorpe, V., Dupont, J., Hill, D., Xu, L., Kapoun, A. M., & Smith, D. C. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.30.15_suppl.3025 · Cited by 11
Messersmith, W. A., LoRusso, P. M., Cleary, J. M., Dasari, A. N., Huang, B., Shaik, N. M., Cesari, R., McLachlan, K. R., Kern, K. A., & Shapiro, G. I. (2012) · European Journal of Cancer · doi:10.1016/s0959-8049(12)72385-7 · Cited by 7
McKeage, M. J., Kotasek, D., Millward, M., Markman, B. R., Jameson, M. B., Hidalgo, M., Harris, D. L., Stagg, R., Dupont, J., & Hughes, B. G. M. (2012) · European Journal of Cancer · doi:10.1016/s0959-8049(12)72395-x · Cited by 4
Nguyen, D., Witter, S., Tomaszewski, J. E., et al. (2012) · Cancer Research · doi:10.1158/1538-7445.am2012-746 · Cited by 1
Self-citation
Cited by
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Sanchez-Vega, F., Mina, M., Armenia, J., Chatila, W. K., Luna, A., La, K. C., Dimitriadoy, S., Liu, D. L., Kantheti, H. S., Saghafinia, S., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.035 · Cited by 3,201
“, 2017), (Aster and Blacklow, 2012), (Takebe et al., 2014), (Buijs et al.”
BackgroundTargeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update
Takebe, N., Miele, L., Harris, P. J., Jeong, W., Bando, H., Kahn, M., Yang, S. X., & Ivy, S. P. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.61 · Cited by 1,298
Self-citationWang, S., Wang, J., Chen, Z., Luo, J., Guo, W., Sun, L., & Lin, L. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00522-z · Cited by 569
Notch signaling: An emerging therapeutic target for cancer treatment
Yuan, X., Wu, H., Xu, H., Xiong, H., Chu, Q., Yu, S., Wu, G. S., & Wu, K. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.07.048 · Cited by 402
Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors
Gounder, M., Ratan, R., Alcindor, T., Schöffski, P., van der Graaf, W. T., Wilky, B. A., Riedel, R. F., Lim, A., Smith, L. M., Moody, S., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2210140 · Cited by 273
Metadata
- Authors
- Takebe, N., Nguyen, D., & Yang, S. X.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2014-02
- Volume
- 141
- Issue
- 2
- Pages
- 140-149
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2019708706
- Cited by
- 413
- References
- 105
- FWCI
- 15.33
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.